ORICOric Pharmaceuticals, Inc.
14.20USD-3.07%Mkt Cap: 1.47B $P/E: —3d ago
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms in cancers in the United States. Its clinical stage produ…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap1.47B $
Enterprise Value1.18B $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-129.47M $
Revenue/Share—
Last Price14.20 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees111
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS68622P1093
Valuation
P/E (Trailing)—
P/E (Forward)-8.60
PEG—
EV/EBITDA-7.61
EV/Revenue—
P/S—
P/B3.77
EPS (TTM)-1.23
EPS (Forward)-1.61
52W Range
7.23091% of range14.93
52W High14.93 USD
52W Low7.230 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-33.68%
ROA-31.66%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-110.97M $
CapEx (TTM)712.00K $
FCF Margin—
FCF Yield-4.68%
Net Debt-258.76M $
Net Debt/EBITDA1.67
Balance Sheet
Debt/Equity0.01
Current Ratio13.19
Quick Ratio12.76
Book Value/Sh3.679 USD
Cash/Share2.554 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)20.67 USD
Upside (mean)+45.5%
Target Range14.00 USD – 27.00 USD
$14.00+45.5% to mean$27.00
# Analysts12
Ownership
Shares Out.103.65M
Float88.69M
Insiders1.59%
Institutions122.72%
Short Interest
Short Ratio13.2d
Short % Float21.26%
Short % Out.21.04%
Shares Short21.80M
Short (prev mo.)22.11M
Technical
SMA 5011.12 (+27.7%)
SMA 20010.61 (+33.9%)
Beta0.97
S&P 52W Chg18.16%
Avg Vol (30d)1.51M
Avg Vol (10d)1.13M
Technical Indicators
RSI (14)64.7
MACD0.9335
MACD Signal0.8592
MACD Hist.+0.0743
BB Upper15.20 USD
BB Middle12.76 USD
BB Lower10.33 USD
BB Width38.13%
ATR (14)0.8282 USD
Vol Ratio (20d)0.56x